ARTICLE | Distillery Therapeutics
Therapeutics: Muscarinic acetylcholine receptor M4 (CHRM4; HM4)
December 10, 2015 8:00 AM UTC
Mouse and non-human primate studies suggest CHRM4 positive allosteric modulators (PAMs) could help treat PD levodopa-induced dyskinesia (PD-LID). In mouse and non-human primate models of PD-LID, a too...